• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect . Near Real-Time Severe Acute Respiratory Illness Surveillance Characterising Influenza and COVID-19 Epidemiology in Hospitalised Adults, 2

tetano

Editor, Senior Moderator
J Infect


. 2024 Nov 1:106338.
doi: 10.1016/j.jinf.2024.106338. Online ahead of print. Near Real-Time Severe Acute Respiratory Illness Surveillance Characterising Influenza and COVID-19 Epidemiology in Hospitalised Adults, 2021-22

Antonia Ho[SUP] 1 [/SUP], Neil McInnes[SUP] 2 [/SUP], Andrew Blunsum[SUP] 2 [/SUP], Joanna Quinn[SUP] 2 [/SUP], Daniel Lynagh[SUP] 3 [/SUP], Michael E Murphy[SUP] 4 [/SUP], Rory Gunson[SUP] 5 [/SUP], Alisdair MacConnachie[SUP] 2 [/SUP], David J Lowe[SUP] 6 [/SUP]



Affiliations
Free article Abstract

Objectives: We report the findings of a novel enhanced syndromic surveillance which characterised influenza- and SARS-CoV-2-associated severe acute respiratory illness (SARI) in the 2021/2022 winter season.
Methods: Prospective cohort study of adults admitted to the Queen Elizabeth University Hospital, Glasgow, with a severe acute respiratory illness. Patient demographics, clinical history, admission details, and outcome were recorded. Data were available to Public Health Scotland (PHS) and clinicians weekly.
Results: Between November 2021 and May 2022, 1,063 hospitalised SARI episodes in 1,037 adult patients were identified. Median age was 72.0 years and 44.5% were male. Most (82.6%) SARI cases had >1 co-morbidity; chronic lung disease (50.0%) and malignancy (22.5%) were the most frequently reported. Overall, 229 (22%) and 33 (3%) SARI episodes were SARS-CoV-2 and influenza A PCR positive, respectively. 74.7%, 6.5% and 43.0% SARI episodes received antibiotics, antivirals, and steroids, respectively (54.5, 11.0 and 51.3% among COVID-19 patients). 1.1% required mechanical ventilation and 7.8% died. Male sex, multimorbidity, frailty, respiratory rate >30, low GCS and chest X-ray consolidation were predictive of in-hospital mortality.
Conclusion: Near real-time hospitalised SARI syndromic surveillance characterised the evolving clinical epidemiology of SARS-CoV-2 and influenza, high antimicrobial use, and predictors of inpatient mortality among hospitalised SARI patients.

Keywords: COVID-19; SARS-CoV-2; influenza; severe acute respiratory illness; syndromic surveillance.

 
Back
Top Bottom